LSI

The LSI USA ‘25 Partnering App is now open! Starting today all LSI USA '25 registered attendees can begin building their profiles, discovering and filtering potential matches, and scheduling one-on-one or group meetings, all designed to maximize partnering opportunities before, after, and during the event. Curious how the partnering app can help you maximize meetings at LSI? In this short clip, investors and strategics who regularly attend LSI events share their insights on making the most of the platform. Watch the 2-minute video here: https://lnkd.in/gQXnyzyu Not yet registered? If you want access to the partnering app and the opportunity to connect with 1,500+ Medtech and Healthtech leaders, register on our website now to get started using the app today.

If you’re presenting at LSI USA ‘25 this video is for you. In our recent webinar, panelists shared key advice on how to make the most of your presentation, both during the event and afterward with the video recording. Here’s their top advice: • Your Presentation is a Content Asset – Think beyond the live audience. The recording is a high-quality resource that can be used long after the event. • Use the Video Strategically – Share it in follow-up emails, investor outreach, or as a quick alternative to a full pitch deck. A concise, well-delivered talk can be more impactful than a lengthy document. • Repurpose the Content – Clip key moments for social media, embed it on your website, or use snippets in investor pitches. The recording extends your reach far beyond the event. • Prepare and Curate Your Presentation – Since the video will live beyond the event, refine your message, ensure clear delivery, and treat it as a polished piece of content. Want to see more of the webinar? Watch the recording here to see how you can best prepare for LSI USA ‘25: https://lnkd.in/gA3iFe8y Still not registered? If you want first access to the partnering app and the opportunity to connect with 1,500+ Medtech and Healthtech leaders, register now to get started using the app today. Thank you to our panelists! • Nick Pachuda, Neovate Capital • Drew Trivisonno, Precision Life Science Partners • Christopher Campbell, Johnson & Johnson • Jeffrey O'Donnell, Jr., Runway Healthcare

We’re just 4 weeks away from LSI USA ‘25, and this year’s event is shaping up to be the premier Medtech gathering of the year. With all presenter spots now officially filled, the lineup of innovators is stronger than ever. Today, we’re excited to reveal a few of the 370 innovators selected to present at the event, taking place March 17-21: • Bart Sanders — STENTiT • Mariam Maghribi — Atia Vision • John Porterfield — Informed Surgical, Inc. • John Schorgl — Peytant Solutions, Inc. • Hannah Zhang — Zepto Life Technology • Kelly Huang, PhD — Elucid • Sarah Sachinis — meduloc • Bart Emery — EerDx • Eliav Shaked 🇮🇱 — RetiSpec Presenter spots may be full, but there are still plenty of ways to get involved: 1. Join the waitlist if you’d still like to present. 2. Apply to exhibit and secure a high-visibility demo and partnering space. 3. Book a 30-minute studio interview to share your story with a professional media package. 4. Register as an attendee and take advantage of unmatched networking opportunities. If you’d like to join us next month at LSI USA ‘25, head to our website, or reach out to our team to learn more about how you can get involved.

LSI USA '25 Panel Just Announced: Demystifying Corporate Development — How to Avoid Common Pitfalls and Run a Best-In-Class Process Corporate development is a critical function that can make or break a company's long-term success. From mergers and acquisitions to strategic investments, the process requires careful planning, precise execution, and a deep understanding of market dynamics. But what separates a smooth, high-value deal from one that stalls or falls apart? This panel will explore the strategies that industry leaders use to navigate corporate development with confidence. The discussion will cover everything from identifying the right opportunities and structuring deals to managing integration challenges and avoiding common missteps that derail success. In this LSI USA ‘25 panel, you’ll hear perspectives from: • Tomer Stavitsky — Executive Corporate Development / Business Development Advisor, Tomer Stavitsky Consulting & Advisory • Justin Montellese — Senior Director Corporate Business Development (M&A), Hologic, Inc. • Jovie Katticaran — Director, M&A and Scaled Investments, DaVita Venture Group • William Phillips — Chairman of the Board of Directors, Factor 7 Medical We are still accepting registrations for a limited time for LSI USA ‘25 on March 17-21 in Dana Point, California. Secure your spot today while space is still available: https://lnkd.in/gS2KF_wr

Hot off the press! The latest edition of The Memo, featuring Eduardo F., CEO of XCath and EndoQuest Robotics™, is out now! Eduardo Fonseca leads not one but two groundbreaking medtech companies, XCath and EndoQuest Robotics, each pioneering advancements in robotic surgery and endovascular interventions. Though distinct, these companies share a common thread: leveraging robotics to enhance precision, access, and patient outcomes. Fonseca’s dual leadership role is a testament to the transformative potential of these technologies and the shared vision across both organizations. “What excites me is the opportunity to work with incredibly passionate KOLs and see the real impact we can have on patient lives,” Fonseca shared. “Both XCath and EndoQuest are developing platform technologies that could fundamentally change their respective fields, much like Intuitive Surgical did with the OR when they started verticalizing their product offering.” As both companies enter pivotal clinical stages, their impact on intracranial endovascular treatment and endoluminal scar-free surgery could reshape entire treatment paradigms. Continue Reading: https://lnkd.in/gXC7faEW Eduardo Fonseca has been selected to present at LSI USA ‘25 this March 17-21. Join us in welcoming Eduardo to the event in Dana Point, CA, where he will share the latest updates on XCath’s technology and development.

Cardiac ablation is making headlines again, and again. Rightfully so, as a transformative shift in atrial fibrillation (AF) treatment continues, and the race between Boston Scientific, Medtronic, Johnson & Johnson MedTech, Abbott, and more is only heating up. This week's edition of The Numbers — our weekly, no-fluff series with market data and insights from LSI's trusted Market Intelligence team — dives into the state and future of cardiac ablation, driven by the shift towards pulsed field ablation (PFA) solutions. We dive into the numbers driving AF and PFA from Market Intelligence, by LSI, explore the history and evolution of energy modalities, share an update on the multinational companies and startups driving this space, and consider what this all means for patients. Healium Medical | Karium Ltd | Field Medical | AtriAN Medical Subscribe to The Numbers here on LinkedIn for weekly market intelligence, and tell us what topics you'd like us to tackle next. PS - Want to connect with leaders like Chris Eso (Medtronic), Michael J. Ryan (Boston Scientific), Celine Martin (Johnson & Johnson), Lisa Earnhardt (Abbott) and more? They will be at LSI USA '25 in Dana Point on March 17-21, 2025. Limited space is still available, and our partnering platform opens of Feb 17th. Link to register — www.lsiusasummit.com

Roses are red, violets are blue, LSI Alumni are making big moves and we’ve got the weekly recap all for you. This week the LSI Alumni raised over $41 million, formed new partnerships, obtained regulatory approvals, and much more on the road to LSI USA ‘25. Your 60-second news recap: 1MED SA → Appointed David Bird as its new Chief Commercial Officer and John Thomas as its new Director of Strategic Delivery. Accelus — Kevin McGann → Announced that its FlareHawk Interbody Fusion System was granted regulatory approval in Brazil by the Brazilian Health Regulatory Agency (ANVISA). CorVista® Health — Adrian Lam, CFA → Appointed Adrian Lam as President and CEO, succeeding Don Crawford, as he retires from his 42-year career in medtech. Exero Medical — Erez Shor → Closed a $12.7M preferred seed financing. Ibex Medical Analytics — Joseph (Yossi) Mossel → Announced that its Ibex Prostate received FDA 510(k) clearance. ImpediMed — Dr Parmjot Bains , MBChB, M Phil, GAICD → Announced a five-year $15M growth capital facility with SWK Holdings to support commercialization activities and growth. Lymphatica Medtech — Marco Pisano → Announced the publication of its latest research: "Advancing women's health with a pioneering implant to treat breast cancer-related lymphedema." Newronika S.p.A. → Successfully closed a €13.6M Series B funding round led by a new investor, Fondazione ENEA Tech e Biomedical. Nina Capital — Marta G. Zanchi, Marc Subirats → Reached the first close of its third fund of €50M. The company plans to utilize the funds to invest in 25 early-stage healthtech founders, with 60% based in Europe and the remaining based in the United States, Canada, Israel, and Australia. OstomySecure — Manish Chand MD MBA PhD → Announced a partnership with AIG Hospital in the trial phase of its Transcutaneous Implant Evacuation System (TIES) IV. Paradromics Inc. — Matt Angle → Announced a strategic investment from NEOM, a large Saudi Arabia-based project intended to be a hub for technological innovation and sustainable living. Vitazi.ai, Inc. — Jeremy Stueven, MD, MBA → Announced partnership with Eye Associates of New Mexico to enhance AI-powered retinal screening. Congratulations to all the LSI Alumni who made major news this week!

The LSI USA '25 Partnering App opens Monday, February 17th. In yesterday’s webinar, the panel shared practical advice on how to maximize your time at the event starting with using the app to schedule meetings early. Their biggest takeaway? Don’t wait. As soon as the app goes live, take time to review the attendee list, identify key people, and send meeting requests right away because calendars fill up fast. Beyond scheduled one-on-ones, the panel emphasized the importance of informal networking. Dinners, lunches, networking receptions, and even hallway conversations create valuable opportunities to build relationships and share your story. The more you engage, the more you’ll get out of the event. Once the app is live, registered attendees can start building their profiles, discovering and filtering potential matches, and scheduling 1:1 or group meetings all designed to help you make the most of your time at LSI USA ‘25. Missed the webinar? No problem. Watch the recording here: https://lnkd.in/gA3iFe8y Still not registered? If you want first access to the partnering app and the opportunity to connect with 1,500+ Medtech and Healthtech leaders, register today to ensure you’re ready when the app opens. Thank you to our panelists! • Nick Pachuda, Neovate Capital • Drew Trivisonno, Precision Life Science Partners • Christopher Campbell, Johnson & Johnson • Jeffrey O'Donnell, Jr., Runway Healthcare

Tetrous, Inc., founded in 2019, is a regenerative medicine company specializing in advanced technologies for enthesis repair in sports medicine applications. The company is led by a team of experienced surgeons, regenerative medicine scientists, and medical device executives. Tetrous has developed the EnFix® family of products, which includes EnFix RC® and EnFix TAC®. These implants are designed to enhance healing at the tendon-to-bone interface, known as the enthesis, which is crucial for procedures like rotator cuff repairs. The EnFix implants utilize proprietary demineralized cortical bone fibers, promoting optimal biologic healing and reformation of the enthesis. Want to learn more about Tetrous? Catch Bradley Patt’s full video presentation from LSI USA ‘24 on our website and YouTube channel. Plus, don’t miss Brad’s return to LSI USA '25 this March, where he will present the latest updates from Tetrous. Want to get involved at LSI USA ‘25? We’re still accepting registrations to attend the event for a limited time. Apply today while space is still available.

The LSI USA '25 Partnering App opens on Monday, February 17th. This will be your hub to connect with 1,500+ Medtech and Healthtech leaders, including top investors, innovators, strategics, and more. Every aspect of LSI USA '25 is designed with partnering and insights sharing in mind, ensuring you maximize high-quality, relevant meetings throughout the event. Once the app goes live, registered attendees can start building their profiles, discovering and filtering potential matches, and scheduling 1-1 or group meetings—all designed to maximize your opportunities before and during the event. Additional tools in the LSI USA '25 Partnering App: • Update your personal and company profile with decks, executive summaries, videos, areas of interest, and much more. • Add sessions to your calendar so you don’t miss presentations, keynotes, fireside chats, workshops, panels, or any other activities of interest. • View and message other registered attendees. • And much more If you want initial access to the partnering app and the opportunity to connect with 1,500+ Medtech and Healthtech leaders, register today to ensure you’re ready when the app opens: https://lnkd.in/gS2KF_wr